Search - tctmd.com

Displaying 41 - 60 of 287

Sort: Relevancy | Date

News Conference News AHA 2024

REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients

L.A. McKeown

November 22, 2024

News Conference News AHA 2024

Indian Patients Do Well on Dual-Combination Pills for Hypertension: TOPSPIN

Caitlin E. Cox

November 22, 2024

News Conference News AHA 2024

Nasal Bumetanide Safe, Effective in Healthy Adults

Yael L. Maxwell

November 18, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

Presentation TCT 2024

First-in-Human Experience with the ModulHeart Device to Support Cardiorenal Function in Acute Decompensated Heart Failure with Diuretic Resistance (Puzzle Medical)

Presenter: Philippe Genereux

October 28, 2024

News Conference News HFSA 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

Caitlin E. Cox

October 03, 2024

News Daily News

Subcutaneous Furosemide Enables HF Patients to Address Congestion at Home

Caitlin E. Cox

September 16, 2024

News Daily News

ACC Updates Pathway for Hospitalized HF Patients

Todd Neale

August 12, 2024

News Daily News

Acute HF Patients Live Longer When Seen by Specialists

Michael O'Riordan

August 09, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

News Daily News

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

L.A. McKeown

August 05, 2024

News Daily News

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Yael L. Maxwell

August 01, 2024

News Daily News

Early, Intense GDMT Improves Decongestion in Acute HF: STRONG-HF

Todd Neale

July 19, 2024

News Conference News ESC Heart Failure 2024

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

Michael O'Riordan

May 21, 2024

News Conference News ESC Heart Failure 2024

Better Natriuresis With IV Furosemide and Metolazone in Chronic HF Patients

Michael O'Riordan

May 13, 2024

News Conference News ESC Heart Failure 2024

Delays to Echo and Diagnosis Spell Poor Early Outcomes in Suspected HF

Michael O'Riordan

May 13, 2024

News Conference News ESC Heart Failure 2024

Remote Monitoring in Real-world HF Cuts All-Cause Mortality: TELESAT-HF

Michael O'Riordan

May 12, 2024

News Conference News ACC 2024

KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives

Shelley Wood

April 11, 2024

Advertisement

REALIZE-K: Potassium Binder Boosts MRA Use in Hyperkalemic HFrEF Patients

Indian Patients Do Well on Dual-Combination Pills for Hypertension: TOPSPIN

Nasal Bumetanide Safe, Effective in Healthy Adults

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

First-in-Human Experience with the ModulHeart Device to Support Cardiorenal Function in Acute Decompensated Heart Failure with Diuretic Resistance (Puzzle Medical)

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

Subcutaneous Furosemide Enables HF Patients to Address Congestion at Home

ACC Updates Pathway for Hospitalized HF Patients

Acute HF Patients Live Longer When Seen by Specialists

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Early, Intense GDMT Improves Decongestion in Acute HF: STRONG-HF

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

Better Natriuresis With IV Furosemide and Metolazone in Chronic HF Patients

Delays to Echo and Diagnosis Spell Poor Early Outcomes in Suspected HF

Remote Monitoring in Real-world HF Cuts All-Cause Mortality: TELESAT-HF

KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content